Bottom line
How has VMVAX performed?
As of Dec 31, 2025, VMVAX returned +12.0% over the past year, +10.7% a year over five years, +9.9% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $25,800. Its five-year return beat 86% of mid-cap funds we track. Its best quarter was +18.7% and its worst −31.4%.
Updated Dec 31, 2025
VMVAX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| VMVAX | +12.0% | +14.0% | +9.8% | −7.9% | +28.8% | +2.5% | +28.0% | −12.4% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in VMVAX
$10,000 invested at the start of 2018 would have been worth about $19,100 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +12.0% | $19,116 |
| 2024 | +14.0% | $17,060 |
| 2023 | +9.8% | $14,961 |
| 2022 | −7.9% | $13,631 |
| 2021 | +28.8% | $14,800 |
| 2020 | +2.5% | $11,494 |
| 2019 | +28.0% | $11,209 |
| 2018 | −12.4% | $8,758 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| VMVAX | +12.0% | +10.7% | +9.9% | — |
| Mid-Cap median | +7.9% | +8.1% | +9.9% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jun 30, 2026, VMVAX returned +5.62%, −0.13%, +2.12% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.